Thrombotic microangiopathy and anti-VEGF agents

被引：67
|
作者：
Izzedine, Hassane [1 ]
Brocheriou, Isabelle
Deray, Gilbert
Rixe, Olivier
机构：
[1] Hop La Pitie Salpetriere, Dept Nephrol, Paris, France
[2] Hop La Pitie Salpetriere, Dept Pathol, Paris, France
[3] Hop La Pitie Salpetriere, Dept Oncol, Paris, France
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2007年 / 22卷 / 05期
关键词：
D O I：
10.1093/ndt/gfl565
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：1481 / 1482
页数：3
相关论文
共 50 条
  • [31] Antineoplastic agents and thrombotic microangiopathy
    Garcia, Gwenalyn
    Atallah, Jean Paul
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (02) : 135 - 142
  • [32] Characteristic morphological changes in anti-VEGF therapy-induced glomerular microangiopathy
    Pfister, Frederick
    Amann, Kerstin
    Daniel, Christoph
    Klewer, Monika
    Buttner, Anke
    Buettner-Herold, Maike
    HISTOPATHOLOGY, 2018, 73 (06) : 990 - 1001
  • [33] Anti-VEGF-related thrombotic microangiopathy in a child presenting with nephrotic syndrome
    Songül Yılmaz
    Z. Birsin Özçakar
    Aysel Taktak
    Saba Kiremitçi
    Arzu Ensari
    Handan Dinçaslan
    Fatoş Yalçınkaya
    Pediatric Nephrology, 2016, 31 : 1029 - 1032
  • [34] Anti-VEGF-related thrombotic microangiopathy in a child presenting with nephrotic syndrome
    Yilmaz, Songul
    Ozcakar, Z. Birsin
    Taktak, Aysel
    Kiremitci, Saba
    Ensari, Arzu
    Dincaslan, Handan
    Yalcinkaya, Fatos
    PEDIATRIC NEPHROLOGY, 2016, 31 (06) : 1029 - 1032
  • [35] VEGF, anti-VEGF and diseases
    Corvol, Pierre
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2008, 192 (02): : 289 - 302
  • [36] The role of VEGF and EGFR inhibition: Implications for combining anti-VEGF and anti-EGFR agents
    Tabernero, Josep
    MOLECULAR CANCER RESEARCH, 2007, 5 (03) : 203 - 220
  • [37] Diabetic retinal disease: an update on the use of anti-VEGF agents
    Davies, Nigel
    Shotliff, Kevin
    PRACTICAL DIABETES, 2013, 30 (02) : 50 - 52
  • [38] Switch of anti-VEGF agents is an option for nonresponders in the treatment of AMD
    C Ehlken
    S Jungmann
    D Böhringer
    H T Agostini
    B Junker
    A Pielen
    Eye, 2014, 28 : 538 - 545
  • [39] Anti-VEGF agents for age-related macular degeneration
    Ozkiris, Abdullah
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2010, 20 (01) : 103 - 118
  • [40] Posterior reversible encephalopathy syndrome induced by anti-VEGF agents
    Tlemsani, Camille
    Mir, Olivier
    Boudou-Rouquette, Pascaline
    Huillard, Olivier
    Maley, Karin
    Ropert, Stanislas
    Coriat, Romain
    Goldwasser, Francois
    TARGETED ONCOLOGY, 2011, 6 (04) : 253 - 258
12345